← Leaderboards
Julie Marie Garcia
University Of California, San Francisco
$108,377
Attributed
$108,377
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $42.1K · FY2021–23$50K$37.5K$25K$12.5K$0
'21
'22
'23
Funding mix
By agency
NIH$108,377 · 1
By mechanism
F31$108,377 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Wendell A Lim$53,669,345
- Hideho Okada$20,052,698
- Arthur Weiss$25,258,536
- Jill Allison Hollenbach$14,012,161
- Orion D Weiner$14,865,661
Others in their field
Other Emerging Leaders on “Antibodies”
- Bambra Strokes · Ppd Development Lp$461,655,950
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$169,304,044
- Yunda Huang · Fred Hutchinson Cancer Center$73,421,550
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Hanjoon Ryu$28,519,898
- Wendy Sammons-Jackson · National Institute Of Allergy And Infectious Diseases$27,369,420
Research focus
AntibodiesComplexArchitectureAntigen BindingAntigensCaliforniaCancer CellCancer ImmunotherapyCancerousCancer TherapyB-LymphocytesCareerCar T Cell TherapyCd8b1 GeneCell GrowthCell KillingCell MembraneCell PhysiologyCellsCell TherapyChimeric Antigen ReceptorChimeric Antigen Receptor T CellsCancer TypeCustom
Grant awards (3)
Engineering Hybrid SynNotch CAR Receptors to Enhance Cell Therapies for Cancer$24,819
F31 · FY2023 · CA · contact PI
Engineering Hybrid SynNotch CAR Receptors to Enhance Cell Therapies for Cancer$42,137
F31 · FY2022 · CA · contact PI
Engineering Hybrid SynNotch CAR Receptors to Enhance Cell Therapies for Cancer$41,421
F31 · FY2021 · CA · contact PI